--- title: "Gongdong Medical released its 2024 annual performance, with a net profit attributable to the parent company of 172 million yuan, a year-on-year increase of 57.28%" type: "News" locale: "en" url: "https://longbridge.com/en/news/236804326.md" description: "Gongdong Medical released its 2024 annual report, with revenue of 1.115 billion yuan, a year-on-year increase of 14.37%; net profit attributable to the parent company of 172 million yuan, a year-on-year increase of 57.28%; net profit excluding non-recurring items of 168 million yuan, a year-on-year increase of 56.18%; basic earnings per share of 1.09 yuan. The company plans to distribute a cash dividend of 4.00 yuan for every 10 shares and to increase its capital by transferring 4 shares for every 10 shares from the statutory surplus reserve" datetime: "2025-04-21T13:18:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/236804326.md) - [en](https://longbridge.com/en/news/236804326.md) - [zh-HK](https://longbridge.com/zh-HK/news/236804326.md) --- # Gongdong Medical released its 2024 annual performance, with a net profit attributable to the parent company of 172 million yuan, a year-on-year increase of 57.28% According to the Zhitong Finance APP, Gongdong Medical (605369.SH) disclosed its annual report for 2024. During the reporting period, the company achieved revenue of 1.115 billion yuan, a year-on-year increase of 14.37%; net profit attributable to the parent company was 172 million yuan, a year-on-year increase of 57.28%; net profit excluding non-recurring gains and losses was 168 million yuan, a year-on-year increase of 56.18%; basic earnings per share were 1.09 yuan. The company plans to distribute a cash dividend of 4.00 yuan (tax included) for every 10 shares to all shareholders and plans to increase capital by transferring 4 shares for every 10 shares to all shareholders using the statutory surplus reserve ### Related Stocks - [605369.CN](https://longbridge.com/en/quote/605369.CN.md) ## Related News & Research - [Comey eyes new 'anti-weaponization' fund: 'I'm guessing I'll be in line'](https://longbridge.com/en/news/286948735.md) - [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md) - [Trump Delivers Confused Rambling After Claiming ’Every Agency' Has 'Scum'](https://longbridge.com/en/news/287086760.md) - [09:06 ETHarmony Comes to the Massachusetts State House as The Platters® Prepare Their Musical Love Letter to the World](https://longbridge.com/en/news/286918739.md) - [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)